Migraine headaches are experienced by approximately 6 million young people in the United States and often result in associated disability (Powers et al., 2021). While the management of migraine headaches regularly involves the use of medication (Silberstein & Goadsby, 2002), little is known about adherence to medication among young people (Ramsey et al., 2014). Responding to this knowledge gap, Reidy et al. (this issue) provide a US-based systematic, multi-modal investigation of adherence in a sample of 328 participants aged 8–17 years. Participants were recruited into the Child and Adolescent Migraine Prevention clinical trial. Adherence was measured over a 6-month period, using subjective and objective monthly measures. Measures included pill counts, self-report daily diary data, and drug serum levels at months’ 3 (end of titration period) and 6 (end of trial). Participants were required to take two pills daily and were randomly assigned either Topiramate,...
- clinical trial
- headache and migraine
ASJC Scopus subject areas
- Developmental and Educational Psychology
- Pediatrics, Perinatology, and Child Health